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Abstract
Background: Neural stem cells (NSCs) are a promising source for cell replacement therapies for neurological
diseases. Growing evidence suggests an important role of cerebrospinal fluid (CSF) not only on neuroectodermal
cells during brain development but also on the survival, proliferation and fate specification of NSCs in the adult
brain. Existing in vitro studies focused on embryonic cell lines and embryonic CSF. We therefore studied the effects
of adult human leptomeningeal CSF on the behaviour of adult human NSCs (ahNSCs).
Results: Adult CSF increased the survival rate of adult human NSCs compared to standard serum free culture
media during both stem cell maintenance and differentiation. The presence of CSF promoted differentiation of
NSCs leading to a faster loss of their self-renewal capacity as it is measured by the proliferation markers Ki67 and
BrdU and stronger cell extension outgrowth with longer and more cell extensions per cell. After differentiation in
CSF, we found a larger number of GFAP
+ astroglial cells compared to differentiation in standard culture media and
a lower number of b-tubulin III
+ neuronal cells.
Conclusions: Our data demonstrate that adult human leptomeningeal CSF creates a beneficial environment for
the survival and differentiation of adult human NSCs. Adult CSF is in vitro a strong glial differentiation stimulus and
leads to a rapid loss of stem cell potential.
Background
Neural stem cells (NSCs) are a promising source for cell
replacement therapies in the brain and the spinal cord
[1]. It is common knowledge that NSCs can be extracted
from fetal brain [2-4] or generated from embryonic stem
cells [2,5-8]. Furthermore, NSCs can also be isolated
from different regions of the adult brain such as the hip-
pocampus and the subventricular zone and from some
non-neurogenic regions such as the spinal cord
[2,3,9-13] or the periventricular regions of the whole
neuroaxis [14]. NSCs are able to replicate and generate
all neuroectodermal lineages, namely neurons, astroglia
and oligodendroglia [2,3,15]. During in vitro expansion,
NSCs grow in so-called “neurospheres” or adherent cul-
tures. Neurospheres are either multicellular aggregates
or clones originating from one single cell depending on
the cell density [3,9,11,15]. In previous studies, the isola-
tion and successful long-term expansion of human
NSCs from the adult hippocampus, the adult olfactory
bulb and adult post-mortem tissues have been reported
[16-20]. In these studies, ahNSCs have successfully been
expanded for more than 30 population doublings using
serum-free culture medium which is normally supple-
mented with the mitogenes epidermal growth factor
(EGF) and fibroblast growth factor 2 (FGF-2). Removal
of the mitogenes leads to spontaneous differentiation of
adult NSCs into neurons, astroglia and oligondendroglia
[16-20].
Investigations examining the influence of CSF and its
contents on survival, proliferation and differentiation of
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avian CSF [21-23]. In these investigations, NSCs cul-
tured in CSF showed an increased survival rate and a
higher number of BrdU positive, DNA synthesizing
nuclei, compared to standard culture media. In addition
a larger number of beta-tubulin III
+, immature neurons,
has been detected compared to standard culture media,
indicating a positive influence of embryonic avian CSF
on neurogenesis. As there are well known differences
between avian and mammalian CSF [24] with a much
greater complexity of mammalian CSF, the transferabil-
ity of these results to human conditions is not yet clear.
Also, they might be a difference in between effects of
adult CSF on NSCs and embryonic CSF effects. Still,
this is not yet investigated, even though it has been sug-
gested that CSF plays an important role not only during
brain development but also for the survival, proliferation
and differentiation of neuroectodermal stem cells in vivo
[21-23,25-27]. In this present study we therefore used
an in vitro cell system of adult human NSCs in culture
as a model to investigate the effects of adult human CSF
on NSC behaviour.
Results
CSF increases the survival rate of adult human NSCs
After in vitro expansion for at least three passages in
standard media, NSCs were transferred to uncoated
chamber slides and expanded in standard expansion
medium or CSF for additional 72 h. Thereafter, cells
were stained with Hoechst 33342 and propidiumiodid to
determine the amount of necrotic cells. Our results
showed a significantly higher survival rate of NSCs in
CSF compared to standard expansion medium (see
Materials and Methods) with 6.9 ± 1.9% of necrotic cells
in CSF versus 46.0 ± 12.9% in expansion medium (P =
0.013; Fig. 1). Addition of the bone morphogenic protein
(BMP) inhibitor Noggin did not significantly increase
cell death rates compared to CSF without Noggin (5.2 ±
2.4% of necrotic cells, P = 0.54; Fig. 1). Similar results
were obtained during in vitro differentiation with signifi-
cantly higher survival rates in CSF compared to stan-
dard differentiation media: After 24 h in P4-8F media,
20.3 ± 2.6% of NSCs were found necrotic versus 10.1 ±
2.9% in CSF (P = 0.021). After 72 h, the proportion was
22.7 ± 7.5% versus 6.5 ± 0.8% for standard media versus
CSF, respectively (P = 0.038; Fig. 2). Again, addition of
Noggin to CSF had no significant influence on the cell
death rate during differentiation for the first 24 h (2.4 ±
1.5% of necrotic cells, P =0 . 0 9w h e nc o m p a r e dC S F
with CSF plus Noggin condition; Fig. 2).
CSF inhibits proliferation of adult human NSCs
To determine the influence of adult human leptomenin-
geal CSF on self-renewal potential of adult NSCs, we
used the proliferation markers Ki67 and BrdU as read-
outs. For this, after in vitro expansion of at least three
passages, cells were transfe r r e dt ou n c o a t e dc h a m b e r
slides and expanded in culture medium or CSF. The self
renewing potential was determined at 24 h (Ki67) and
72 h (BrdU) after media was changed. At each time
point, the percentage of Ki67
+ and BrdU
+ NSCs was sig-
nificantly higher in expansion medium compared to the
one in CSF, representing a larger number of proliferat-
ing cells in expansion media. Hence, after 24 h Ki67 was
detected in 20.4 ± 7.3% of NSCs expanded in standard
medium compared to only 0.2 ± 0.01% of NSCs
expanded in CSF (P = < 0.001; Fig. 3). For BrdU, we
detected 42.8 ± 15.7 BrdU
+ cells/cm
2 in KO-DMEM,
but only 2.4 ± 2.8 BrdU
+ cells/cm
2 in CSF (P = 0.023,
Fig. 3).
CSF increases extension outgrowth velocity from adult
human NSCs
W eu s e dt h et i m ec o u r s eo fe x t e n s i o no u t g r o w t ha sa
first measure of the differentiation process of NSCs in
culture. Thus, following expansion for at least three pas-
sages in vitro NSCs were allowed to differentiate. Cells
were plated onto PLL-coated chamber slides in either
differentiation media or CSF. For investigating extension
outgrowth, number and length of extensions were deter-
mined at 0, 3, 6, 24 and 72 h after starting the differen-
tiation process. Comparing results in P4-8F and CSF, we
found significantly longer and a significantly more cell
extensions per cell in CSF. After 24 and 72 h the differ-
ence was significant as NSC neurites getting twice as
long in CSF (mean length: 14.5 ± 2.6 and 33.2 ± 1.4 μm
after 24 and 72 h, respectively) as in P4-8F (mean
length: 7.7 ± 0.9 and 10.6 ± 3.2; P =0 . 0 2 4[ 2 4h ]a n d
0.001 [72 h]; Fig. 4). Significant more cell extensions
were determined in CSF for the time points 6 h, 24 h
and 72 h with an average number of 1.3 ± 0.0 cell
extensions in CSF after 6 h compared to 1.2 ± 0.1 neuri-
tis in P4-8F. After 24 h, the mean number of cell exten-
sions was 1.5 ± 0.1 in CSF versus 1.2 ± 0.1 in P48F and
after 72 hours cells had at an average of 2.0 ± 0.1 cell
extensions in CSF compared to 1.5 ± 0.1 in P4-8F
respectively.(P = 0.001, 0.008 and 0.005, respectively;
Fig. 4).
CSF facilitates astrogliogenesis but inhibits neurogenesis
from adult human NSCs
To investigate the question whether the presence of
adult human leptomeningeal CSF does have an influence
on astrogliogenesis, oligodendrogenesis or neurogenesis,
adult NSCs were allowed to differentiate for 7 days on
PLL-coated chamber slides in either standard differen-
tiation media or CSF. After differentiation in standard
media, 24.7 ± 1.7% of the cells were GFAP
+, in contrast
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+ cells in CSF (P = 0.014; Fig. 5). The
values for GalC
+ oligodendroglial cells and MAP2
+ neu-
rons were 8.2 ± 2.6% GalC
+ and 0.2 ± 1.7 MAP2
+ cells
in standard media and 7.0 ± 1.5 GalC
+ and 0.4 ± 0.6
MAP2
+ cells in CSF (P > 0.05). The low percentage of
MAP2
+ cells in standard media and CSF is most likely
caused by the lack of fully differentiated phenotypes, as
MAP2 represents a marker for mature neurons. Staining
against the neuronal marker protein b-tubulin III, a
marker for immature neurons, revealed 8.7 ± 3.6% b-
tubulin III
+ cells in CSF compared to 30.7 ± 8.4 b-tubu-
lin III
+ cells in standard media (P = 0.014).
Figure 1 Survival rate of human adult NSCs during expansion. A, The percentage of necrotic NSCs expanded in culture medium
supplemented with EGF and FGF-2 in comparison to CSF with or without 150 ng/ml Noggin was determined 72 hours after starting the
expansion process. Values represent the mean ± S.E.M from at least three independent experiments. * indicates P < 0.05 and ** P < 0.01
compared to each corresponding value in CSF. B, Representative microphotographs demonstrating the influence of CSF on survival rate of NSCs.
For immunostainings, dead cells were stained with propidiumiodid. Nuclei were counterstained with Hoechst 33342. The upper panel shows
NSCs expanded in CSF (left photograph) and CSF+Noggin (right photograph), the lower panel shows NSCs expanded in expansion media
supplemented with EGF and FGF. Scale bar = 50 μm.
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Page 3 of 11Figure 2 Survival rate of adult human NSCs during proliferation. A, The percentage of necrotic NSCs was determined at 24 and 72 hours
after differentiation on PLL-coated chamber slides in P4-8F or CSF with or without 150 ng/ml Noggin. Values represent the mean ± S.E.M from
at least three independent experiments. * indicates P < 0.05 and ** P < 0.01 compared to each corresponding value in CSF. B, Representative
microphotographs demonstrating the influence of CSF on the survival rate of NSCs. For immunostainings, dead cells were stained with
propidiumiodid. Nuclei were counterstained with Hoechst 33342. The upper panel shows NSCs differentiated in differentiation media P4-8F, the
middle panel shows NSCs differentiated in CSF, and the lower panel shows NSCs differentiated in CSF+Noggin. Scale bar = 50 μm.
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Page 4 of 11Figure 3 Investigation of cell proliferation in adult human NSCs during expansion. The portion of NSCs with potential to self renewal
expanded in culture medium supplemented with EGF and FGF-2 or CSF without additional growth factors was determined 24 and 72 hours
after medium change. A, Percentage of Ki67
+ cells after 24 h, number of BrdU
+ cells per cm
2 after 72 h. Values represent the mean ± S.E.M from
at least three independent experiments. *indicates P < 0.05 and ** P < 0.01 compared to each corresponding value in CSF. B, Representative
microphotographs demonstrating the influence of CSF on proliferation markers in NSCs. For immunostainings cells were stained with anti-BrdU
(upper panel) and anti-Ki67 (lower panel) and anti-Nestin (upper and lower panel). Nuclei were counterstained with DAPI (lower panel). Altered
morphology of neurospheres with CSF treatment (right panel) is most likely due to the beginning differentiation process. Scale bar = 50 μm.
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Page 5 of 11Figure 4 Cell extension outgrowth in adult human NSCs. A, Length of cell extensions (μm) after 1, 3, 6, 24, 72 hours of differentiation in P4-
8F or adult human CSF. B, Number of cell extensions at 1, 3, 6, 24, 72 hours of differentiation in P4-8F or human adult CSF. A and B, Values
represent the mean ± S.E.M from at least three independent experiments. * indicates P < 0.05 compared to each corresponding value in CSF.
C, Representative microphotographs showing cell morphology after 1, 3, 6, 24, 72 hours of differentiation in CSF. Scale bar = 50 μm.
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Page 6 of 11Figure 5 Neurogenesis and gliogenesis from adult human NSCs. A, The percentage of GFAP
+, MAP2ab
+, b-tubulin III and GALC
+ cells after
differentiation for 10 to 14 days in KO/DMEM or CSF. Results are mean values ± S.E.M from at least three independent experiments. * indicates
P < 0.05 compared to each corresponding value in CSF. B, Representative microphotographs demonstrating the effects of CSF on neuronal and
glial differentiation of ahNSCs 10 to 14 days after initiation of the differentiation process. Cells were stained with anti-GFAP, anti-b-tubulin III and
anti-GALC. Nuclei were counterstained with DAPI. Scale bar = 50 μm.
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There is growing evidence that CSF plays an important
role in physiological as well as pathophysiological pro-
cesses of the brain including adult neurogenesis
[28-30]. In a very recent study of our group, we found
adult human leptomeningeal CSF being a promotor of
survival, differentiation and astrogliogenesis of fetal
NSCs from rat [31]. The influence of CSF on adult
NSCs remains however still enigmatic. In this study we
therefore used human adult NSCs as an in vitro model
to study the effects of adult leptomeningeal CSF on
NSC behaviour including survival, self renewal and dif-
ferentiation. The central finding of our study is that in
vitro, adult CSF promotes survival and differentiation
of ahNSCs, but drives the differentiation process
towards astrogliogenesis. In accordance with these
findings, the loss of stem cell potential is accelerated
when cultured in adult CSF. These findings suggest
that adult CSF contains key factors involved in the
control of cellular proliferation and differentiation pro-
cesses. This assumption is supported by in vivo find-
ings, demonstrating that adult NSCs of the
subventricular zone have transitory contact with the
ventricular brain cavity and many of them still posses
one microcilia which extends into the CSF [32-35]. In
addition, it is known from previous studies [21-23]
that embryonic CSF has a trophic influence on survival
and differentiation of NSCs. However, the loss of stem
cell potential is decelerated, which is contradictory to
our findings in adult CSF and may explain the abun-
dance of post-mitotic cells in adult CNS.
Based on the knowledge of embryonic CSF studies, it
has already been postulated that diffusible factors in
embryonic CSF regulate the three basic cellular beha-
vioural parameters of neuroephitelial stem cells and that
embryonic CSF may play a key role in brain develop-
ment in vivo [23].
However, how CSF influences neuroectodermal cells
during development remains enigmatic, but the compo-
nents contained in CSF as well as CSF pressure and flow
seem to play an important role [26,36]. Regarding the
components of CSF influencing neuroectodermal cell
behaviour, recent investigations concentrated mainly on
proteins, “membranous particles” and amino acids but
also on growth factors such as FGF2 [21,24,25,36,37]. In
a v i a na n dh u m a nC S F ,m a n yp r o t e i n sw i t hak n o w n
influence on cell survival, neural and glial differentiation,
proliferation and signal transduction were found (such as
transthyretin, serin, retinol binding protein, heparan sul-
fate, several apolipoproteins, and FGF2) [22,24,25].
Although it has also been demonstrated that the protein
composition of embryonic CSF is more complex than
that of adult CSF [22], our results indicate that adult CSF
has the capacity to influence the behaviour of adult NSCs
in the adult brain, too.
CSF as a beneficial environment for cell survival and
growth has also been postulated by in vivo studies,
investigating for example the behaviour of fetal NSCs
after injection in the fourth ventricle of spinal cord
lesioned rats with a good survival of grafted cells within
the CSF [38,39], as well as in a recent in vitro study of
our own group with fetal rat NSCs [31]. In the present
study, CSF had a general stimulating effect demon-
strated by the faster loss of self-renewing capacity and
stronger cell extension outgrowth. Adult hNSCs differ-
entiated predominantly into astrocytes (38% in CSF,
25% in standard media) when treated with CSF and to a
lower extend into oligodendrocytes and neurons. After
differentiation for 7 days, we found 9% of the cells to be
b-tubulin
+ in CSF. In standard culture media, 31% of
the cells were b-tubulin III
+. Therefore, our data
strongly suggest inhibitory effects of CSF on neurogen-
esis of ahNSCs, but promoting effects on astroliogenesis.
Possible factors in CSF influencing differentiation beha-
viour of NSCs are bone morphogenetic proteins
(BMPs): Monoclonal antibodies against BMP7 were for
example shown to inhibit CSF induced dendritic out-
growth of neurons. BMP4 was shown to induce neuro-
nal differentiation of NSCs by activating the ERK and
inhibiting the GSK3b pathway. Both described effects
could be blocked by Noggin, a BMP inhibitor [40,41].
These described effects of BMPs, do have an influence
on neuronal differentiation only in fetal NSCs from rat.
Until recently, it remained elusive whether these BMPs
may also play a role in the observed effects of adult
human CSF on astroglial differentiation, but we could
show that parts of the CSF mediated effects on fetal rat
NSCs could be blocked by Noggin[31]. BMPs thus seem
to be at least a part of the soluble factors in the CSF
influencing stem cell behaviour in fetal rat NSCs. How-
ever, in the present work, we could not find any inhibit-
ing effects of Noggin on CSF survival effects on adult
human NSCs. This raises the question whether BMPs
influence NSC behaviour only during ontogenesis and
therefore have no influence on NSCs derived from the
adult brain or whether BMPs might differential effects
in human and rat cell systems.
It is well accepted that lumbar CSF is different from
ventricular CSF because of both passive diffusion pro-
cesses across the blood-CSF-barrier and suggested active
secretion processes during the cranio-caudal circulation
[42]. Consistently, all herein described CSF effects can
only be attributed to leptomeningeal CSF. Whether ven-
tricular CSF has similar same effects on NSC behaviour
remains elusive. The use of CSF out of ventricular drai-
nages is however problematic, as ventricular drainages
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example cerebral aqueduct stenosis) or other reasons of
elevated brain pressure with defect blood-brain- and
blood-CSF-barrier (for example after major stroke, after
intracerebral bleedings or inoperable brain tumours).
Furthermore, CSF out of ventricular drainages is often
contaminated by blood and altered by inflammatory
processes, which is why it cannot be used for the exami-
nation of healthy CSF effects.
Conclusions
Together, our results demonstrate that adult leptome-
ningeal CSF has a trophic influence on adult human
NSCs: survival and differentiation into astroglial cells
are promoted. Thus, our data point to a pivotal role of
CSF in regulating adult neurogenesis under physiological
and presumably also under pathological conditions as
suggested previously [28-30]. Future experiments are
warranted to determine which compounds within the
CSF, besides BMPs, might be responsible for the effects
on NPC behaviour. It also needs to be investigated
whether there are different CSF compounds influencing
the behaviour of NSCs originating from fetal or adult
brain. This might give us the opportunity to influence
resident NSCs of the SVZ to induce their proliferation
as well as to promote their migration to pathologically
altered brain regions.
Methods
Collection of adult human leptomeningeal CSF
The CSF samples were taken for diagnostic purpose
from adult patients in the Neurological Clinic of the
Ernst Moritz Arndt University of Greifswald by a lum-
bar puncture. Scientific use of CSF samples was
approved by the local Ethics Committee. All patients
gave a written informed consent for the diagnostic pro-
cedure. Lumbar puncture was performed by standard
protocols. The final diagnosis of all patients was Idio-
pathic Normal Pressure Hydrocephalus (NPH). CSF was
only used if all standard parameters were normal (cell
count, glucose-, lactate. and albumin-content, immuno-
globulin-quotient). Contamination with blood was
excluded. In all patients, tumors and infectious diseases
were excluded. Surplus CSF from diagnostic samples of
all patients was spun down to remove remaining cells,
pooled and analyzed to exclude non-sterility and pre-
s e n c eo fi n f l a m m a t o r ym a r kers. The pooled CSF was
normal in all standard parameters; contamination with
blood was excluded once again. The exact parameters
were as follows: Cell count <1/μl, no blood contamina-
tion, normal protein of 369 mg/l, normal glucose of 3.6
mmol/l, normal lactate of 2.0 mmol/l, normal ferritine
of 7.2 μg/l, normal albumin quotient of 5.0 × 10
-3,n o r -
mal immunoglobulin quotients: IgG 2.1 × 10
-3,I g A
1.1 × 10
-3,I g M< 0 . 2×1 0
-3. Pooled CSF samples were
aliquoted and frozen at -80° until used.
Isolation and propagation of adult human neural stem
cells (ahNSCs)
Adult human hippocampal tissue was obtained from
routine epilepsy surgery procedures (selective amygdalo-
hippocampectomia) following informed consent of the
patients. All procedures were in accordance with the
Helsinki convention and approved by the ethics com-
mittees at the EMA University of Greifswald (III UV 77/
06) and at Dresden University of Technology
(EK47032006). The tissue was stored in ice-cold Hank’s
balanced salt solution (HBSS) supplemented with 11
mM glucose and 1% penicillin/streptomycin. In all
patients, tumours and infectious diseases were excluded
by means of high-resolution magnetic resonance ima-
ging and screening for inflammatory markers. Addition-
ally, neuropathological tissue examination did not reveal
evidence for tumour formation. For expansion of neuro-
spheres, tissue samples were dissociated using trypsin,
DNase and mechanical trituration similar as described
previously [19]. Several media and supplements were
tested like DMEM, DMEM/F12, Neurobasal (all from
Gibco), P4-8F (Athena) with and without N2 or B27
supplements (Gibco) and growth factors. Best results
concerning especially the amount of primary neuro-
spheres per dissected hippocampal tissue and the early
passage propagation was achieved by Knock-Out
DMEM medium, supplemented with 10% KO supple-
ment; 0.5 mM glutamine; 1% penicillin/streptomycin (all
from Gibco) and 20 ng/ml both EGF and FGF-2 (from
Sigma-Aldrich)(KO/DMEM). Therefore this medium
was chosen as control expansion medium. Cultures
were incubated at 37°C in a humidified atmosphere and
lowered O2 conditions of 5% CO2, 92% N2 and 3 ± 2%
O2. Fresh medium was added once a week, growth
factors twice a week. For BrdU labelling, cells were incu-
bated with 10 μm BrdU for 72 h. For immunocytochem-
istry studies of neurospheres, these were allowed to
attach for 2-4 h before been fixed as described below.
Differentiation conditions
Cells were differentiated by plating them onto poly-L-
lysine-coated chamber slides or 6-well-plates in P4-8F
(standard differentiation media; from AthenaES, Balti-
more, MD, USA, the albumin-content of P4-8F of
250 μg/ml matches the normal albumin content of
healthy adult lumbar CSF, the glucose content of P4-8F
is in a physiological concentration of 7 mmol/l) or in
CSF without adding any growth factors. Some of the dif-
ferentiation experiments were conducted in the presence
of 150 ng/ml recombinant Noggin (R&D System, Min-
neapolis, MN). For studying cell survival, proliferation
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for up to 72 hours, for investigating cell fate decisions
for up to 7 days respectively. Half of the media was
changed every third day. For investigating cell morphol-
ogy, survival rate and marker expression by immunocy-
tochemistry, the cultures were fixed from 0 h up to 72 h
and 14 days after starting the differentiation process.
Immunostainings
For immunocytochemistry, cell cultures were fixed in
4% paraformaldehyde in PBS or with 4% paraformalde-
hyde/PBS followed by ice-cold acidic ethanol and 2N
HCL for BrdU staining. Immuncytochemistry was car-
ried out using standard protocols. Cell nuclei were
counter stained with 4,6-diamidino-2-phenylindole
(DAPI). To determine the self renewing potential of
NPCs, Ki67 expression and BrdU incorporation were
used. Ki67 is detected in the nucleus of proliferating
cells in all active phases of the cell cycle from the late
G1 phase though the M-phase [43,44]. BrdU marks
cells within the S-phase of the cell cycle [45]. Antibo-
dies and dilutions were as follows: rabbit anti-glial fibril-
lary acidic protein (GFAP) polyclonal 1:1000 (Chemicon
International, Temecula, CA, USA), mouse anti-micro-
tubuli associated protein (MAP2ab) monoclonal 1:100
(Pharmingen, San Diego, CA, USA), mouse anti-galacto-
cerebroside (GalC) monoclonal 1:500 (Chemicon), rab-
bit anti-b-tubulin III (Tuj1) monoclonal 1:1000
(Covance, Emeryville, CA, USA), rabbit anti-Ki67 poly-
clonal 1:500 (Berlin Chemie AG, Berlin, Germany),
mouse anti-BrdU 1:16 (Roche Applied Science, Man-
nheim, Germany) and secondary antibodies conjugated
to Alexa 488 and 594 1:500 (Gibco/Invitrogen, Carlsbad,
CA, USA).
For determining the survival rate during expansion
and differentiation, dead cells were stained with propi-
diumiodid (PI) 1:50 (Sigma Aldrich, St. Louis, USA), cell
nuclei were counter stained with Hoechst 33342 1:1000
(Sigma Aldrich, St. Louis, USA). Images were captured
using inverse fluorescence microscopes (DMIL and
DMI4000, Leica; Wetzlar, Germany).
Cell counts, measurements of neurites and statistics
For quantification of the percentage of cells expressing a
g i v e nm a r k e r ,t h en u m b e ro fp o s i t i v ec e l l so fa tl e a s t
five representative areas per experiment was determined
relative to the total number of DAPI/Hoechst-labelled
nuclei, or field of view in cm
2 where appropriate. Neur-
ite lengths were measured with a semi-automatic dis-
tance measurement computer program (VisRoute®). In a
typical experiment, a total number of 500 to 1,000 cells
were counted per marker, and 500 to 1,000 neurites per
time point were measured. The mean values of ≥ 3
experiments for each condition are given together with
standard deviations. Statistical comparisons were made
by ANOVA with post-hoc t-test or Dunnett’s t-test
where appropriate. P-values < 0.05 were considered as
statistically significant.
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